Position in BSX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,757,733
-$799,266 QoQ
Shares Held
41,184
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#586
of 1,468 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GF FUND MANAGEMENT CO. LTD. holds $27,271,599 across 13 Medical Devices names. BSX ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
104,224 | $6,671,378 | |
| 2 | DXCM |
Dexcom Inc
|
88,596 | $5,966,940 | |
| 3 | ABT |
Abbott Laboratories
|
47,558 | $4,315,412 | |
| 4 | SYK |
Stryker Corp
|
9,408 | $2,962,014 | |
| 5 | MDT |
Medtronic plc
|
35,120 | $2,747,437 | |
| 6 | BSX |
Boston Scientific Corp
This page
|
41,184 | $1,757,733 | |
| 7 | EW |
Edwards Lifesciences Corp
|
16,089 | $1,455,410 | |
| 8 | STE |
STERIS plc
|
2,710 | $570,644 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,757,733 | 41,184 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,556,999 | 40,749 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,885,417 | 40,749 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,053,402 | 41,518 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,331,858 | 31,020 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,152,701 | 31,252 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,791,428 | 31,252 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||